Skip to main content
. 2020 Sep 11;73(11):e4499–e4506. doi: 10.1093/cid/ciaa1372

Table 3.

Association of Antibiotic Overuse After Discharge With 30-Day Adverse Outcomes

Outcomes at 30 days Patients with antibiotic overuse after discharge, n = 10 709, n (%) Patients without antibiotic overuse after discharge, n = 11 116, n (%) Unadjusted OR per day of antibiotic overuse (95% CI) Unadjusted P value Adjusted OR per day of antibiotic overuse (95% CI) Adjusted P value
Composite adverse outcome 2485 (23.2) 2938 (26.4) .98 (.97–.99) <.001 .99 (.97–1.00) .15
Mortality 224 (2.1) 365 (3.3) .94 (.90–.97) <.001 .99 (.94–1.05) .83
Readmission 1333 (12.4) 1654 (14.9) .97 (.95–.98) <.001 .98 (.96–1.01) .21
Emergency department visit 1269 (11.8) 13 988 (12.5) .99 (.98–1.01) .28 .99 (.97–1.01) .28
Clostridioides difficile infection 45 (.4) 58 (.5) .96 (.89–1.05) .38 1.01 (.94–1.08) .79
Provider-documented adverse events 167 (1.6) 176 (1.6) 1.01 (.98–1.04) .71 1.01 (.98–1.04) .60
Patient-reported adverse eventsa 167/5302 (3.1) 90/2585 (3.5) 1.02 (.99–1.05) .18 1.02 (.99–1.05) .20

Outcomes collected via the medical record and a follow-up telephone call at 30 days, and their associations with number of days of antibiotic overuse after discharge are shown. n = 21 825. P values are shown for unadjusted or odds ratios adjusted for hospital clustering, inverse probability of treatment, and known predictors of the outcome of interest (see Supplementary Appendix for details). P values <.05 are significant.

Abbreviations: CI, confidence interval; OR, odds ratio.

a Data were only collected on patient-reported adverse events if the patient was discharged on antibiotics. The proportions shown include only eligible patients who were able to be reached by telephone.